Showing 6,008 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Changing treatment

Outcomes of HIV Virologic Suppression After Switching to Dolutegravir/Lamivudine

Editor's pick
Infectious Disease Advisor
28 March 2022
Changing treatment

17 months average wait to switch from a failing HIV treatment regimen in African countries

News
28 March 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period

Editor's pick
ViiV press release
25 March 2022
Improving HIV care

Medical mistrust is linked to discrimination, poor care engagement, and low adherence among Black adults in the US

News
21 March 2022
Economic & social inequality

Income May Be the Biggest Determinant of Whether Women Stay on PrEP

Editor's pick
POZ
18 March 2022
Treatment outcomes & life expectancy

Readmission, Mortality are Post-Discharge Risks for HIV Patients

Editor's pick
Contagion Live
17 March 2022
PEP

Study shows Biktarvy for PEP has fewer side effects and better completion rates

News
16 March 2022
Viral load

Undetectable viral load Illustrated

About HIV
March 2022
Resistance

How long will it take for HIV to develop resistance to my medications?

About HIV
March 2022
Changing treatment

If I change treatment and find that I don’t like my new meds, can I go back to the old ones?

About HIV
March 2022
Sleep

Fatigue and HIV

About HIV
March 2022
Injectable & long-acting HIV treatment

US: Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician

Editor's pick
FiercePharma
9 March 2022
Side effects

Peripheral neuropathy and HIV

About HIV
March 2022
Bone & joint problems

Better adherence to PrEP is associated with more bone loss

News
9 March 2022
Health problems & ageing

Pain and HIV

About HIV
March 2022
Injectable & long-acting HIV treatment

Injectable cabotegravir plus rilpivirine every two months maintains viral suppression for three years, but carries higher risk of treatment failure

News
8 March 2022
New & experimental HIV treatments

Top 5 HIV treatment stories from CROI 2022

News
2 March 2022
The search for a cure

Top 5 HIV cure and vaccine stories from CROI 2022

News
2 March 2022
New & experimental HIV treatments

U.S. FDA declines to approve Gilead's HIV drug on glass vial concerns

Editor's pick
Reuters
1 March 2022
Coronavirus

Top 5 stories on HIV treatment and care in Africa from CROI 2022

News
1 March 2022
Ageing & HIV

aidsmapLIVE: Decades of HIV Video

February 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022
New & experimental HIV treatments

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

News
23 February 2022